Through a collaboration between the Canadian Geriatrics Society (CGS) and Pfizer, the CGS is pleased to announce the creation of an award to support either clinical fellows or residents in training to conduct a relevant research project in the area of overactive bladder and urinary incontinence in older persons. Recipients will be granted up to $10,000 over a 12 month period. There may be more than one recipient in which case the $10,000 funds will be shared between the recipients.
Aim and Scope: The aim of this award is to support resident / fellow research projects that promote excellence in overactive bladder and urinary continence care for older people.
Objective:To support research from trainees (Residents/Fellows) in Geriatric Medicine / Care of the Elderly, ideally producing peer reviewed published scholarly work in the field of overactive bladder and urinary incontinence.
Wednesday, March 31, 2021
CRITERIA & ELIGIBILITY
Applicants should be members of the CGS at the time of application.
Applicants will be a member of a Canadian residency or training program in either Geriatric Medicine or Care of the Elderly or in a fellowship program after completion of a Geriatric Medicine or Care of Elderly residency.
Clinical, translational or interventional trials
Outcomes / epidemiological research (pharmacoeconomics / economics / disease management)
Secondary analysis of existing data sets
Quality improvement and educational scholarship
Any proposal that includes a clinical trial involving human participants must be conducted according to ICH and Health Canada guidelines, and conform to the Declaration of Helsinki regarding human subjects in research.
The award cannot be used for part funding of a larger project unless the portion of the larger project for which the award is made is separate and distinguishable (i.e. will result in a stand-alone publication).
Proposals for projects that have received funding from other sources.
Studies involving the administration / aiming to support the efficacy of a competitor drug or the use of a generic
Projects consisting of fundamental (basic) research will not be considered.
Proposals will be reviewed by a panel of no fewer than three members comprised of or appointed by the CGS Awards committee. A medical affairs representative of the sponsor will be a non-voting member of the review panel.
Proposals will be evaluated on the following criteria:
Scientific merit: potential for contribution of knowledge in the field, relevance
Feasibility: proposed design, method and analysis, proposed timelines.
Guidelines for submission
An application should be submitted by the Resident / Fellow who must have as a supervisor who is an active member of CGS. The supervisor will acknowledge supervision and overall responsibility for the project. Funds will be made available to the supervisor / supervisor’s institution.
Applications will include:
Project proposal not exceeding 5 single spaced pages (Arial 11pt font).
References may be included as an appendix (maximum 30)
Applications should be structured as follows:
Statement of the problem
Background / literature review
Methods / Setting / Population
Project budget with justification
CV of applicant and supervisor (CIHR academic CV)
Letter of support from supervisor – this should describe the research environment/facilities available to the applicant making the proposed project feasible.
Applications should be made online, addressed to The Awards Committee, Continence Fellowship Award and emailed to: email@example.com.
CGS Awards Committee and Pfizer representative and an additional expert will review applications and recommend a recipient for the award to the CGS Executive. If there are no suitable winners, the committee reserves the right not to present the award in any given year.
Awardee(s) will be notified by May 10, 2021.
The proposed project must be completed within 12 months of receipt of funding.
A no-cost 6 month extension can be applied for in cases of unanticipated delay.
Peer reviewed publication of the project should ideally occur not more than 18 months following completion of the project.
Award recipients are expected to submit an abstract to the CGS Annual Scientific meeting (and others where applicable/allowable) and to submit their work for publication in peer -reviewed journals. All publications and products of scholarship emanating from the award should be acknowledged as follows:
Research made possible by the Canadian Geriatrics Society – Pfizer Continence Research Fellowship Award.
RECOGNITION OF RECIPIENT
The award will be recognized at the CGS Annual Scientific Meeting held virtually from May 26 - May 28, 2021. Awarded research funds will be available to the supervisor/ institution on May 31, 2021.